<DOC>
	<DOCNO>NCT00214981</DOCNO>
	<brief_summary>Primary objective study evaluate safety treatment modafinil film-coated tablet .</brief_summary>
	<brief_title>Evaluate Safety Efficacy Modafinil Children Adolescents With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Patients include study participate previous qualify study modafinil , opinion investigator , continue benefit treatment modafinil . In addition , follow criterion must meet : boy girl 6 17 year age , inclusive , Englishspeaking weight height 5th 95th percentile National Center Health Statistics ( NCHS ) growth chart age , height , weight 6 month since last dose study drug , meet full DSMIV crieria ADHD ( combine typd , predominantly inattentive type , predominantly hyperactive impulsive type ) screening , manifest psychiatric/clinical evaluation confirm structured diagnostic interview , namely , Diagnostic Interview Schedule Children , Fourth Edition ( DISCIV ) . good health ( except diagnosis ADHD ) determine medical psychiatric history , physical examination , ECG , serum chemistry , hematology , urinalysis girl child bear potential ( Tanner scale &gt; 3 ) OR girl 8 year age older negative urine pregnancy test screening , must use medically acceptable method birth control , must agree continue use method duration study ( 30 day participation study ) . ( NOTE : For conduct pregnancy test , investigator option determine sexual maturity girl 8 year age old . ) Acceptable method birth control include : barrier method spermicide ; steroidal contraceptive ( eg , oral , transdermal , implanted , inject ) conjunction barrier method ; intrauterine device ( IUD ) ; abstinence parent legal guardian willing participate study . Patients exclude participate study 1 follow criterion meet : history current diagnosis pervasive developmental disorder , schizophrenia , psychotic disorder , clinical assessment current suicide risk current psychiatric comorbidity , include limited depression mood disorder , anxiety disorder , pervasive mental disorder , require pharmacotherapy clinically significant drug sensitivity stimulant amphetamine , dextroamphetamine , methylphenidate , pemoline failure respond 2 adequate course ( dose duration ) ADHD therapy use prescription medication ADHD ( e.g. , amphetamine , dextroamphetamine , methylphenidate , pemoline , atomoxetine ) screen visit use MAO inhibitor SSRIs within 2 week baseline visit hypertension , define follow ( SBP = systolic blood pressure DBP = diastolic blood pressure ) : age 69 year SBP &gt; 122mmHg DBP &gt; 78mmHg age 1012 year SBP &gt; 126mmHg DBP &gt; 82mmHg age 1317 year SBP &gt; 136mmHg DBP &gt; 86mmHg hypotension , define sit systolic blood pressure ( take rest 5 minute ) less 50mmHg child 12 year age less 80mmHg child 12 old sit pulse outside range 60 115 bpm rest 5 minute</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit/Hyperactivity Disorder</keyword>
</DOC>